מדיקינט MR כמוסות בשחרור מושהה 20 מ"ג

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

METHYLPHENIDATE HYDROCHLORIDE 20 MG

Disponible depuis:

MEDILINE LTD.

Code ATC:

N06BA04

forme pharmaceutique:

MODIFIED RELEASE CAPSULES

Mode d'administration:

PER OS

Fabriqué par:

MEDICE ARZNEIMITTEL PUETTER GMBH & CO.KG, GERMANY

Groupe thérapeutique:

METHYLPHENIDATE

indications thérapeutiques:

Medikinet Modified Release Capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (ADHD) in children over 6 years of age when remedial measures alone prove insufficient. Treatment must be under the supervision of a specialist in childhood behavioural disorders. Diagnosis should be made according to DSM-IV criteria or the guidelines in ICD-10.

Date de l'autorisation:

2011-05-01